Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Cortavance   
Auth. number : EU/2/06/069
Active substance : Hydrocortisone aceponate
ATC: Anatomical main group: QD - Dermatologicals
Therapeutic subgroup: QD07 - Corticosteroids, dermatological preparations
Pharmacological subgroup: QD07A - Corticosteroids, plain
Chemical subgroup: QD07AC - Corticosteroids, potent (group III)
Chemical substance: QD07AC16 - hydrocortisone aceponate
(See WHO ATCvet Index)
Indication: For symptomatic treatment of inflammatory and pruritic dermatoses in dogs.
Marketing Authorisation Holder: VIRBAC S.A.
1ère Avenue - 2065 m - L.I.D., 06516 Carros CEDEX, France
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/01/2007 Centralised - Authorisation EMEA/V/C/110 (2007)91 of 9/01/2007
12/02/2007 Centralised - Variation EMEA/V/C/110/IA/1
Updated with Decision(2007)4238 of 07/09/2007
11/09/2007 Centralised - Variation (2007)4238 of 7/09/2007
7/07/2010 Centralised - Variation EMEA/V/C/110/II/2 (2010)4716 of 2/07/2010
15/09/2011 Centralised - Renewal EMEA/V/C/110/R/3 (2011)6524 of 13/09/2011
16/08/2013 Centralised - Variation EMEA/V/C/110/IB/6
Updated with Decision(2014)6192 of 26/08/2014
28/08/2014 Centralised - Yearly update (2014)6192 of 26/08/2014
21/12/2016 Centralised - Variation EMEA/V/C/110/IG/724/8
Updated with Decision(2018)143 of 09/01/2018
11/01/2018 Centralised - Yearly update (2018)143 of 9/01/2018